Search
for
Sort by
Research 61–90 of 1000+
- Estimation of biological heart age using cardiovascular magnetic resonance radiomics
- Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Cardiovascular effects of hormone therapy for prostate cancer
- Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Feasibility and acceptability of an online multicomponent very low-carbohydrate intervention in young adult women with obesity: a pilot study
- Severe cutaneous adverse reactions to drugs
- Gender Differences in Cardiac Hypertrophy
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Adverse health effects of androgen use
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Androgenic Effects on Ventricular Repolarization
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Ottawa, Ontario, Canada, February 13–16, 2013
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Update on the dermatologic use of systemic glucocorticosteroids
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Transforming growth factor-β in stem cells and tissue homeostasis
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance